Quarterly report pursuant to Section 13 or 15(d)

Business and Summary of Significant Accounting Policies - Additional Information (Details)

v3.21.2
Business and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Allowance for doubtful accounts $ 0   $ 0   $ 0
Advertising Expense $ 152,000 $ 65,000 $ 451,000 $ 81,000  
Warrant          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4,475,424 7,337,199 4,475,424 7,337,199  
Restricted Stock          
Number of restricted shares granted 310,000   310,000    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 711,805 98,669 711,805 98,669  
Restricted stock units          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 456,931   456,931    
Series A Preferred Stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   250,000   250,000  
Accounts Receivable | Customer Concentration Risk One          
Concentration Risk, Percentage     63.00%   36.00%
Accounts Receivable | Customer Concentration Risk Two          
Concentration Risk, Percentage         31.00%
Accounts Receivable | Customer Concentration Risk Three          
Concentration Risk, Percentage         15.00%
Sales Revenue, Net | Customer Concentration Risk One          
Concentration Risk, Percentage   30.00% 33.00% 54.00%  
Sales Revenue, Net | Customer Concentration Risk Two          
Concentration Risk, Percentage 12.00% 18.00% 17.00% 28.00%  
Sales Revenue, Net | Customer Concentration Risk Three          
Concentration Risk, Percentage 12.00% 15.00% 10.00% 11.00%  
Sales Revenue, Net | Customer Concentration Risk Four          
Concentration Risk, Percentage   11.00%